UniProt ID | TMED9_HUMAN | |
---|---|---|
UniProt AC | Q9BVK6 | |
Protein Name | Transmembrane emp24 domain-containing protein 9 | |
Gene Name | TMED9 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 235 | |
Subcellular Localization |
Endoplasmic reticulum membrane Single-pass type I membrane protein. Golgi apparatus, cis-Golgi network membrane Single-pass type I membrane protein. Endoplasmic reticulum-Golgi intermediate compartment membrane Single-pass type I membrane protein. Golg |
|
Protein Description | Appears to be involved in vesicular protein trafficking, mainly in the early secretory pathway. In COPI vesicle-mediated retrograde transport involved in the coatomer recruitment to membranes of the early secretory pathway. Increases coatomer-dependent activity of ARFGAP2. Thought to play a crucial role in the specific retention of p24 complexes in cis-Golgi membranes; specifically contributes to the coupled localization of TMED2 and TMED10 in the cis-Golgi network. May be involved in organization of intracellular membranes, such as of the ER-Golgi intermediate compartment and the Golgi apparatus. Involved in ER localization of PTPN2 isoform PTPB.. | |
Protein Sequence | MAVELGVLLVRPRPGTGLGRVMRTLLLVLWLATRGSALYFHIGETEKKCFIEEIPDETMVIGNYRTQLYDKQREEYQPATPGLGMFVEVKDPEDKVILARQYGSEGRFTFTSHTPGEHQICLHSNSTKFSLFAGGMLRVHLDIQVGEHANDYAEIAAKDKLSELQLRVRQLVEQVEQIQKEQNYQRWREERFRQTSESTNQRVLWWSILQTLILVAIGVWQMRHLKSFFEAKKLV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
49 | Glutathionylation | IGETEKKCFIEEIPD CCCCCCEEEEEECCC | 6.51 | 22555962 | |
71 | Ubiquitination | YRTQLYDKQREEYQP EECCCHHHCHHHHCC | 37.38 | - | |
71 | 2-Hydroxyisobutyrylation | YRTQLYDKQREEYQP EECCCHHHCHHHHCC | 37.38 | - | |
80 | Phosphorylation | REEYQPATPGLGMFV HHHHCCCCCCCCEEE | 25.27 | 25022875 | |
90 | Ubiquitination | LGMFVEVKDPEDKVI CCEEEEECCHHCCEE | 54.80 | 21906983 | |
95 | 2-Hydroxyisobutyrylation | EVKDPEDKVILARQY EECCHHCCEEEEEEC | 29.52 | - | |
95 | Ubiquitination | EVKDPEDKVILARQY EECCHHCCEEEEEEC | 29.52 | - | |
125 | N-linked_Glycosylation | HQICLHSNSTKFSLF CEEEEECCCCEEEEE | 42.84 | 12754519 | |
125 | N-linked_Glycosylation | HQICLHSNSTKFSLF CEEEEECCCCEEEEE | 42.84 | 12754519 | |
136 | Sulfoxidation | FSLFAGGMLRVHLDI EEEECCCEEEEEEEE | 1.80 | 28465586 | |
152 | Phosphorylation | VGEHANDYAEIAAKD CCCCCCCHHHHHHHH | 13.12 | - | |
158 | Ubiquitination | DYAEIAAKDKLSELQ CHHHHHHHHHHHHHH | 46.50 | - | |
160 | Acetylation | AEIAAKDKLSELQLR HHHHHHHHHHHHHHH | 53.88 | 26051181 | |
160 | Ubiquitination | AEIAAKDKLSELQLR HHHHHHHHHHHHHHH | 53.88 | 21906983 | |
162 | Phosphorylation | IAAKDKLSELQLRVR HHHHHHHHHHHHHHH | 41.84 | - | |
180 | Acetylation | EQVEQIQKEQNYQRW HHHHHHHHHHHHHHH | 64.00 | 26051181 | |
180 | Ubiquitination | EQVEQIQKEQNYQRW HHHHHHHHHHHHHHH | 64.00 | 21906983 | |
198 | Phosphorylation | RFRQTSESTNQRVLW HHHHCCHHHHHHHHH | 32.21 | - | |
226 | Ubiquitination | VWQMRHLKSFFEAKK HHHHHHHHHHHHHHH | 38.81 | 21906983 | |
226 | 2-Hydroxyisobutyrylation | VWQMRHLKSFFEAKK HHHHHHHHHHHHHHH | 38.81 | - | |
226 | Acetylation | VWQMRHLKSFFEAKK HHHHHHHHHHHHHHH | 38.81 | 24575541 | |
232 | Ubiquitination | LKSFFEAKKLV---- HHHHHHHHHCC---- | 39.17 | - | |
232 | 2-Hydroxyisobutyrylation | LKSFFEAKKLV---- HHHHHHHHHCC---- | 39.17 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TMED9_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TMED9_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TMED9_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TMEDA_HUMAN | TMED10 | physical | 22939629 | |
MA2A1_HUMAN | MAN2A1 | physical | 9472029 | |
STX5_HUMAN | STX5 | physical | 9472029 | |
TMED1_HUMAN | TMED1 | physical | 9472029 | |
TMED2_HUMAN | TMED2 | physical | 9472029 | |
TMEDA_HUMAN | TMED10 | physical | 9472029 | |
GALT_HUMAN | GALT | physical | 9472029 | |
P53_HUMAN | TP53 | physical | 9472029 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-125, AND MASSSPECTROMETRY. | |
"Identification and quantification of N-linked glycoproteins usinghydrazide chemistry, stable isotope labeling and mass spectrometry."; Zhang H., Li X.-J., Martin D.B., Aebersold R.; Nat. Biotechnol. 21:660-666(2003). Cited for: GLYCOSYLATION AT ASN-125. |